查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2085557

不孕症檢測市場：2026-2032年全球市場預測（依產品類型、檢測類型、檢體類型、技術、最終用戶和檢測方法分類）

Fertility Testing Market by Product Type, Test Type, Sample Type, Technology, End User, Mode Of Testing - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 185 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，不孕症檢測市場將成長至 133.4 億美元，複合年成長率為 10.33%。

主要市場統計數據
基準年 2025 67億美元
預計年份：2026年 73.8億美元
預測年份 2032 133.4億美元
複合年成長率 (%) 10.33%

不孕症檢測正從一項狹義的臨床服務轉向更廣泛的生殖健康篩檢，涵蓋卵巢儲備功能檢測、精液分析、排卵預測、激素水平檢測、基因篩檢以及輔助生殖技術（ART）前的傳染病檢查。這種需求源自於可衡量的現實。世界衛生組織（WHO）的數據顯示，全球約有六分之一的成年人患有不孕症，因此及時診斷是公共衛生和計劃生育領域的重中之重。

生育年齡的成長、男性不孕症認知的提高、體外受精技術的興起以及居家不孕症檢測的日益普及，正在共同塑造著這個市場。世界衛生組織也意識到，男性和女性因素均是導致不孕症的重要原因，因此，人們對全面不孕症評估的需求日益成長，而不僅限於針對女性的檢測。對於醫療服務提供者、檢測實驗室和醫療設備製造商而言，最大的商機在於臨床準確性、消費者便利性、數位化結果解讀以及實證諮詢的整合。

不孕症檢測領域的變革性變化

不孕症檢測領域正經歷結構性變革，從間歇性不孕症檢測轉向更早期、更具預防性的生殖健康評估。抗穆氏管荷爾蒙）檢測、濾泡刺激素）檢測、黃黃體激素）監測、甲狀腺功能檢測、催乳素檢測、精液分析和經陰道超音波檢查等檢測方法正日益聯合應用，以指南臨床決策並最佳化轉診時機。

人工智慧（AI）的累積影響

人工智慧 (AI) 透過改善影像分析、模式識別和個人化風險分層，正在加速不孕症檢測的發展。在臨床實踐中，人工智慧驅動的工具正被評估用於精子形態評估、胚胎影像解讀、卵泡追蹤以及結合年齡、卵巢儲備指標、精液參數、內分泌指標和先前治療史的預測模型。

關鍵區域洞察

北美憑藉其先進的檢查室基礎設施、廣泛的生殖內分泌服務、輔助生殖技術（ART）報告系統以及對數位健康管道的積極運用，仍然是生育力檢測的重要區域。歐洲擁有完善的ART網路和高標準的服務要求，但歐盟的資料保護和醫療設備框架要求企業確保更強的證據、可追溯性和透明度。以巴西和墨西哥為首的拉丁美洲正透過私人生育診所、都市區診斷網路以及改善生殖內分泌服務的可及性取得進展，但成本效益和公共保險覆蓋範圍的不均衡仍然是其廣泛應用的障礙。

關鍵區域洞察

東協地區不孕症檢測需求的成長主要受以下因素驅動：私人醫療保健的擴張、數位醫療的普及、都市區收入的提高以及大都會圈居民對延遲妊娠意識的增強。海灣合作理事會（GCC）地區以對高階醫療保健、專科診所和醫療旅遊的大量投資為特徵，生殖醫學領域尤其注重檢查室品質、醫生主導的諮詢以及文化因素，這些都是關鍵的競爭優勢。歐盟則強調規範的診斷、病患資料的保護、循證臨床路徑以及在不斷變化的監管要求下對體外診斷醫療設備性能的更嚴格監管。

主要國家的概況

美國在家庭生育力檢測、輔助生殖技術（ART）診斷、數位生殖醫學和專業生殖內分泌服務方面處於創新領先地位。加拿大則著重於規範化的檢測服務、醫生主導的醫療模式以及各省之間公平的醫療服務取得途徑。墨西哥和巴西是拉丁美洲重要的成長市場，這得益於其遍布各地的私人生育診所網路、都市區便利的診斷服務以及不斷成長的中產階級需求。英國、德國、法國、義大利和西班牙受益於成熟的生殖醫學體系、完善的檢測標準以及公眾對生育力保存和輔助生殖技術取得途徑的積極討論。同時，俄羅斯則透過大規模都市區醫療中心和專科診所維持市場需求。

為行業領導者提供的實用建議

產業領導者應優先考慮經臨床檢驗的檢測方案，這些方案應整合卵巢儲備、排卵、內分泌、精液、遺傳、感染疾病和超音波檢查的結果，以實現一致的不孕症評估。特別應重視家用不孕症檢測產品的準確性、參考範圍、經醫生審核的報告以及明確的局限性，因為消費者可能會過度解讀單一生物標記，例如抗穆氏管荷爾蒙(AMH)。

調查方法

本執行摘要基於公共衛生機構、監管機構、同行評審文獻、臨床指南、生育協會出版刊物、醫療保健基礎設施指標以及公開可用的生殖健康資料集的二手研究。主要參考文獻包括世界衛生組織（世衛組織）全球不孕症估計數據、國家生殖健康統計數據、輔助生殖技術（ART）報告系統、診斷檢查室標準以及醫療設備和體外診斷醫療設備的監管指南。

結論

隨著患者對儘早獲得答案的需求日益成長，臨床醫生需要全面診斷，醫療保健系統也面臨對輔助生殖技術服務的持續需求，不孕症檢測正成為進入生殖醫學的關鍵切入點。該領域正從傳統的診所檢測擴展到結合檢查室、數位工具、遠端醫療、醫生主導的評估和居家檢體採集等混合模式。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章：不孕症檢測市場：依產品類型分類

  • 耗材和工具包
  • 儀器/分析儀
  • 影像和診斷系統
  • 軟體和數位監控解決方案
  • 檢查服務

第8章：不孕症檢測市場：依檢測類型分類

  • 女性不孕症檢查
    • 排卵測試
    • 卵巢功能檢查
    • 生殖荷爾蒙檢測
    • 子宮和輸卵管檢查
    • 子宮頸黏液和陰道健康檢查
    • 基因不孕症檢測
  • 男性不孕症檢查
    • 精液分析
    • 精子功能測試
    • 精子DNA碎片化檢測
    • 男性生殖荷爾蒙檢測
    • 基因不孕症檢測
    • 睪丸和陰囊影像
  • 夫婦不孕症檢查
    • 相容性及合併不孕症評估
    • 懷孕前篩檢
    • 共基因帶因者篩檢

第9章：不孕症檢測市場：依樣本類型分類

  • 尿
  • 血
  • 唾液
  • 精液
  • 子宮頸黏液
  • 陰道拭子
  • 組織和切片檢查檢體

第10章：不孕症檢測市場：依技術分類

  • 側向流動免疫檢測
  • 酵素免疫分析法（ELISA）
  • 化學冷光免疫檢測
  • 聚合酵素鏈鎖反應
  • 次世代定序
  • 微流體技術
  • 診斷影像
  • 數位和基於感測器的監測

第11章：不孕症檢測市場：依最終用戶分類

  • 診斷檢查室
  • 不孕症治療診所
  • 醫院
  • 居家照護用戶
  • 研究機構

第12章：不孕症檢測市場：依檢測方法分類

  • 家庭測試
  • 檢查室檢測
  • 即時檢測

第13章：不孕症檢測市場：按地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第14章：不孕症檢測市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章：不孕症檢測市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第17章：公司簡介

  • CooperSurgical, Inc.
  • Church & Dwight Co., Inc.
  • Vitrolife AB
  • Abbott Laboratories
  • Danaher Corporation
  • F. Hoffmann-La Roche Ltd.
  • Laboratory Corporation of America Holdings
  • Quest Diagnostics Incorporated
  • Siemens Healthineers AG
  • Illumina, Inc.
  • Revvity, Inc.
  • Hamilton Thorne Inc.
  • Thermo Fisher Scientific Inc.
  • Inito Health Inc.
  • DiaSorin SpA
  • Guangzhou Wondfo Biotech Co., Ltd.
  • Reproductive Genetic Innovations, LLC
  • Easy Healthcare Corporation
  • Ava AG
  • ExSeed Health ApS
  • Fellow Health, Inc.
  • Fulgent Genetics, Inc.
  • Give Legacy, Inc.
  • Medical Electronic Systems Limited
  • MFB Fertility, Inc.
  • Quanovate Tech Inc.
  • QuidelOrtho Corporation
  • Sandstone Diagnostics, Inc.
  • SPD Swiss Precision Diagnostics GmbH
  • viO HealthTech Limited
Product Code: MRR-4348D129FB2F

The Fertility Testing Market is projected to grow by USD 13.34 billion at a CAGR of 10.33% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 6.70 billion
Estimated Year [2026] USD 7.38 billion
Forecast Year [2032] USD 13.34 billion
CAGR (%) 10.33%

Fertility testing is moving from a narrowly clinical service into a broader reproductive health diagnostics category that spans ovarian reserve testing, semen analysis, ovulation prediction, hormone panels, genetic screening, and infectious disease testing before assisted reproductive technology. Demand is grounded in measurable need: the World Health Organization reports that infertility affects about 1 in 6 adults globally, making timely diagnosis a public health and family-planning priority.

The market is shaped by delayed parenthood, higher awareness of male-factor infertility, wider use of in vitro fertilization, and growing acceptance of at-home fertility testing. The WHO also recognizes that both male and female factors contribute substantially to infertility, strengthening demand for integrated fertility assessment rather than female-focused testing alone. For healthcare providers, laboratories, and device manufacturers, the strongest opportunities sit at the intersection of clinical accuracy, consumer convenience, digital interpretation, and evidence-based counseling.

Transformative Shifts in the Fertility Testing Landscape

The fertility testing landscape is being reshaped by a shift from episodic infertility workups to earlier, proactive reproductive health assessment. Anti-Mullerian hormone testing, follicle-stimulating hormone panels, luteinizing hormone monitoring, thyroid testing, prolactin testing, semen analysis, and transvaginal ultrasound are increasingly used together to guide clinical decisions and improve referral timing.

Consumer behavior is also changing. At-home sample collection, app-connected ovulation tracking, direct-to-consumer hormone tests, and telehealth consultations are reducing barriers to first-line testing. However, clinical validation, laboratory quality systems, privacy protection, and physician interpretation remain decisive differentiators as regulators and clinicians scrutinize claims tied to fertility prediction. The sector is also moving toward whole-patient reproductive health models that incorporate age, menstrual history, endocrine status, lifestyle risks, sexually transmitted infection screening, and male-factor evaluation.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is accelerating fertility testing by improving image analysis, pattern recognition, and personalized risk stratification. In clinical settings, AI-supported tools are being evaluated for sperm morphology assessment, embryo image interpretation, follicle tracking, and prediction models that combine age, ovarian reserve markers, semen parameters, endocrine profiles, and prior treatment history.

The cumulative impact is not replacement of clinicians but better triage, consistency, and workflow efficiency. Adoption will depend on transparent model validation, diverse training datasets, explainable outputs, cybersecurity controls, and alignment with medical device regulations. Companies that pair AI with clinically verified diagnostics can strengthen confidence while reducing time to actionable fertility guidance, especially when algorithmic outputs are positioned as decision support and reviewed within established clinical pathways.

Key Regional Insights

North America remains a high-value fertility testing region because of advanced laboratory infrastructure, broad availability of reproductive endocrinology services, ART reporting systems, and strong use of digital health channels. Europe benefits from established assisted reproduction networks and strong quality expectations, while the European Union's data protection and medical device frameworks are pushing companies toward stronger evidence, traceability, and transparency. Latin America, led by Brazil and Mexico, is advancing through private fertility clinics, urban diagnostic networks, and improving access to reproductive endocrinology services, although affordability and uneven public coverage continue to shape uptake.

Asia-Pacific is expanding rapidly as China, India, Japan, South Korea, and Australia experience delayed childbearing, urbanization, rising infertility awareness, and broader use of diagnostic chains and assisted reproduction services. The Middle East, particularly GCC economies, is investing in specialty care, premium hospitals, and medical tourism-oriented fertility services, with demand influenced by cultural expectations around family formation. Africa shows long-term potential as diagnostic capacity, affordability, laboratory access, and reproductive health infrastructure improve, while current needs remain significant because infertility carries medical, social, and psychological consequences across many communities.

Key Group Insights

ASEAN fertility testing demand is supported by expanding private healthcare, digital health adoption, rising urban incomes, and increasing awareness of delayed conception in metropolitan populations. The GCC is characterized by high investment in premium healthcare, specialist clinics, and medical tourism, making laboratory quality, physician-led counseling, and culturally sensitive reproductive care important competitive factors. The European Union emphasizes regulated diagnostics, patient data protection, evidence-based clinical pathways, and stronger oversight of in vitro diagnostic performance under evolving regulatory requirements.

BRICS economies combine large population bases with uneven access, creating opportunities for scalable, cost-effective hormone testing, semen analysis, ovulation monitoring, and referral-linked fertility assessment. G7 countries lead in advanced reproductive medicine, ART reporting, reimbursement discussions, digital health integration, and AI-enabled diagnostics, while NATO markets overlap with many high-income healthcare systems where resilience, cybersecurity, data governance, and supply-chain assurance are increasingly relevant for diagnostic continuity and patient trust.

Key Country Insights

The United States leads in innovation across at-home fertility testing, ART-linked diagnostics, digital reproductive health, and specialist reproductive endocrinology services, while Canada emphasizes regulated laboratory services, physician-guided care, and equitable access across provinces. Mexico and Brazil are important Latin American growth markets due to private fertility clinic networks, urban diagnostic access, and rising middle-class demand. The United Kingdom, Germany, France, Italy, and Spain benefit from mature reproductive medicine ecosystems, established laboratory standards, and public debate around fertility preservation and assisted reproduction access, whereas Russia maintains demand through large urban healthcare centers and specialist clinics.

China and India represent major volume opportunities supported by population scale, delayed marriage in urban areas, expanding diagnostic chains, and growing awareness of both female and male infertility. Japan and South Korea face persistent low fertility rates, which increases policy and consumer attention on reproductive health, fertility preservation, and earlier diagnostic evaluation. Australia combines advanced clinical standards with strong fertility awareness, well-developed pathology services, and high digital health readiness, while South Korea also stands out for technology adoption in diagnostics and reproductive medicine.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize clinically validated test menus that connect ovarian reserve, ovulation, endocrine, semen, genetic, infectious disease, and ultrasound-supported results into a coherent fertility assessment. Accuracy, reference ranges, physician-reviewed reporting, and clear limitations should be presented prominently, especially for at-home fertility testing products where consumers may otherwise overinterpret single biomarkers such as anti-Mullerian hormone.

Growth strategies should combine partnerships with fertility clinics, OB-GYN networks, urologists, laboratories, employers, pharmacies, and telehealth platforms. Companies should invest in privacy-by-design architecture, AI governance, culturally relevant education, and affordable testing formats for emerging markets. The most defensible brands will translate complex fertility biomarkers into actionable, ethical, and medically responsible guidance while ensuring that abnormal results trigger timely clinical referral.

Research Methodology

This executive summary is built using secondary research from public health agencies, regulatory bodies, peer-reviewed literature, clinical guidelines, fertility society publications, healthcare infrastructure indicators, and publicly available reproductive health datasets. Key reference points include the World Health Organization's global infertility estimates, national reproductive health statistics, ART reporting systems, diagnostic laboratory standards, and medical device and in vitro diagnostic regulatory guidance.

The research approach triangulates epidemiology, technology adoption, regulatory direction, healthcare access, clinical utility, and regional demand signals. Insights are screened for relevance to fertility testing products and services, including hormone assays, semen analysis, ovulation tests, ultrasound-supported evaluation, genetic screening, infectious disease testing, and AI-enabled interpretation tools. Findings are presented without market sizing, market share, or forecasting to maintain focus on verified qualitative and data-backed industry intelligence.

Conclusion

Fertility testing is becoming a critical entry point for reproductive healthcare as patients seek earlier answers, clinicians require integrated diagnostics, and health systems face sustained demand for assisted reproduction services. The category is expanding beyond clinic-based testing into hybrid models that combine laboratories, digital tools, telehealth, physician interpretation, and at-home sample collection.

Future market leadership will depend on trust. Organizations that demonstrate clinical validity, regulatory discipline, privacy protection, inclusive education, and responsible AI deployment will be best positioned across developed and emerging markets. Fertility testing is no longer only a diagnostic step; it is a strategic foundation for personalized reproductive care, earlier intervention, and more informed family-planning decisions.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Fertility Testing Market, by Product Type

  • 7.1. Consumables & Kits
  • 7.2. Instruments & Analyzers
  • 7.3. Imaging And Diagnostic Systems
  • 7.4. Software And Digital Monitoring Solutions
  • 7.5. Laboratory Testing Services

8. Fertility Testing Market, by Test Type

  • 8.1. Female Fertility Testing
    • 8.1.1. Ovulation Testing
    • 8.1.2. Ovarian Reserve Testing
    • 8.1.3. Reproductive Hormone Testing
    • 8.1.4. Uterine And Fallopian Tube Testing
    • 8.1.5. Cervical Mucus And Vaginal Health Testing
    • 8.1.6. Genetic Fertility Testing
  • 8.2. Male Fertility Testing
    • 8.2.1. Semen Analysis
    • 8.2.2. Sperm Function Testing
    • 8.2.3. Sperm DNA Fragmentation Testing
    • 8.2.4. Male Reproductive Hormone Testing
    • 8.2.5. Genetic Fertility Testing
    • 8.2.6. Testicular And Scrotal Imaging
  • 8.3. Couple Fertility Test
    • 8.3.1. Compatibility And Joint Fertility Assessment
    • 8.3.2. Preconception Screening
    • 8.3.3. Shared Genetic Carrier Screening

9. Fertility Testing Market, by Sample Type

  • 9.1. Urine
  • 9.2. Blood
  • 9.3. Saliva
  • 9.4. Semen
  • 9.5. Cervical Mucus
  • 9.6. Vaginal Swab
  • 9.7. Tissue & Biopsy Samples

10. Fertility Testing Market, by Technology

  • 10.1. Lateral Flow Immunoassay
  • 10.2. Enzyme-Linked Immunosorbent Assay
  • 10.3. Chemiluminescence Immunoassay
  • 10.4. Polymerase Chain Reaction
  • 10.5. Next-Generation Sequencing
  • 10.6. Microfluidics
  • 10.7. Imaging-Based Diagnostics
  • 10.8. Digital And Sensor-Based Monitoring

11. Fertility Testing Market, by End User

  • 11.1. Diagnostic Laboratories
  • 11.2. Fertility Clinics
  • 11.3. Hospitals
  • 11.4. Home Care Users
  • 11.5. Research Institutes

12. Fertility Testing Market, by Mode Of Testing

  • 12.1. At-Home Testing
  • 12.2. Laboratory-Based Testing
  • 12.3. Point-Of-Care Testing

13. Fertility Testing Market, by Region

  • 13.1. Asia-Pacific
  • 13.2. North America
  • 13.3. Latin America
  • 13.4. Europe
  • 13.5. Middle East
  • 13.6. Africa

14. Fertility Testing Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Fertility Testing Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Concentration Analysis, 2025
    • 16.1.1. Concentration Ratio (CR)
    • 16.1.2. Herfindahl Hirschman Index (HHI)
  • 16.2. Recent Developments & Impact Analysis, 2025
  • 16.3. Product Portfolio Analysis, 2025
  • 16.4. Benchmarking Analysis, 2025

17. Company Profiles

  • 17.1. CooperSurgical, Inc.
  • 17.2. Church & Dwight Co., Inc.
  • 17.3. Vitrolife AB
  • 17.4. Abbott Laboratories
  • 17.5. Danaher Corporation
  • 17.6. F. Hoffmann-La Roche Ltd.
  • 17.7. Laboratory Corporation of America Holdings
  • 17.8. Quest Diagnostics Incorporated
  • 17.9. Siemens Healthineers AG
  • 17.10. Illumina, Inc.
  • 17.11. Revvity, Inc.
  • 17.12. Hamilton Thorne Inc.
  • 17.13. Thermo Fisher Scientific Inc.
  • 17.14. Inito Health Inc.
  • 17.15. DiaSorin S.p.A
  • 17.16. Guangzhou Wondfo Biotech Co., Ltd.
  • 17.17. Reproductive Genetic Innovations, LLC
  • 17.18. Easy Healthcare Corporation
  • 17.19. Ava AG
  • 17.20. ExSeed Health ApS
  • 17.21. Fellow Health, Inc.
  • 17.22. Fulgent Genetics, Inc.
  • 17.23. Give Legacy, Inc.
  • 17.24. Medical Electronic Systems Limited
  • 17.25. MFB Fertility, Inc.
  • 17.26. Quanovate Tech Inc.
  • 17.27. QuidelOrtho Corporation
  • 17.28. Sandstone Diagnostics, Inc.
  • 17.29. SPD Swiss Precision Diagnostics GmbH
  • 17.30. viO HealthTech Limited

LIST OF FIGURES

  • FIGURE 1. GLOBAL FERTILITY TESTING MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL FERTILITY TESTING MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL FERTILITY TESTING MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL FERTILITY TESTING MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL FERTILITY TESTING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL FERTILITY TESTING MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 7. GLOBAL FERTILITY TESTING MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 8. GLOBAL FERTILITY TESTING MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL FERTILITY TESTING MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL FERTILITY TESTING MARKET SIZE, BY TEST TYPE, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL FERTILITY TESTING MARKET SIZE, BY TEST TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL FERTILITY TESTING MARKET SIZE, BY SAMPLE TYPE, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL FERTILITY TESTING MARKET SIZE, BY SAMPLE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL FERTILITY TESTING MARKET SIZE, BY TECHNOLOGY, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL FERTILITY TESTING MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL FERTILITY TESTING MARKET SIZE, BY END USER, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL FERTILITY TESTING MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL FERTILITY TESTING MARKET SIZE, BY MODE OF TESTING, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL FERTILITY TESTING MARKET SIZE, BY MODE OF TESTING, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL FERTILITY TESTING MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL FERTILITY TESTING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL FERTILITY TESTING MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 23. GLOBAL FERTILITY TESTING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 24. GLOBAL FERTILITY TESTING MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 25. GLOBAL FERTILITY TESTING MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL FERTILITY TESTING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL FERTILITY TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL CONSUMABLES & KITS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL CONSUMABLES & KITS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL CONSUMABLES & KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL INSTRUMENTS & ANALYZERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL INSTRUMENTS & ANALYZERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL INSTRUMENTS & ANALYZERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL IMAGING AND DIAGNOSTIC SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL IMAGING AND DIAGNOSTIC SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL IMAGING AND DIAGNOSTIC SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL SOFTWARE AND DIGITAL MONITORING SOLUTIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL SOFTWARE AND DIGITAL MONITORING SOLUTIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL SOFTWARE AND DIGITAL MONITORING SOLUTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL LABORATORY TESTING SERVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL LABORATORY TESTING SERVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL LABORATORY TESTING SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL FERTILITY TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL FEMALE FERTILITY TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL FEMALE FERTILITY TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL FEMALE FERTILITY TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL OVULATION TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL OVULATION TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL OVULATION TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL OVARIAN RESERVE TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL OVARIAN RESERVE TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL OVARIAN RESERVE TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL REPRODUCTIVE HORMONE TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL REPRODUCTIVE HORMONE TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL REPRODUCTIVE HORMONE TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL UTERINE AND FALLOPIAN TUBE TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL UTERINE AND FALLOPIAN TUBE TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL UTERINE AND FALLOPIAN TUBE TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL CERVICAL MUCUS AND VAGINAL HEALTH TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL CERVICAL MUCUS AND VAGINAL HEALTH TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL CERVICAL MUCUS AND VAGINAL HEALTH TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL GENETIC FERTILITY TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL GENETIC FERTILITY TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL GENETIC FERTILITY TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL MALE FERTILITY TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL MALE FERTILITY TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL MALE FERTILITY TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL SEMEN ANALYSIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL SEMEN ANALYSIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL SEMEN ANALYSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL SPERM FUNCTION TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL SPERM FUNCTION TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL SPERM FUNCTION TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL SPERM DNA FRAGMENTATION TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL SPERM DNA FRAGMENTATION TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL SPERM DNA FRAGMENTATION TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL MALE REPRODUCTIVE HORMONE TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL MALE REPRODUCTIVE HORMONE TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL MALE REPRODUCTIVE HORMONE TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL GENETIC FERTILITY TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL GENETIC FERTILITY TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL GENETIC FERTILITY TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL TESTICULAR AND SCROTAL IMAGING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL TESTICULAR AND SCROTAL IMAGING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL TESTICULAR AND SCROTAL IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL COUPLE FERTILITY TEST MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL COUPLE FERTILITY TEST MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL COUPLE FERTILITY TEST MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL COMPATIBILITY AND JOINT FERTILITY ASSESSMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL COMPATIBILITY AND JOINT FERTILITY ASSESSMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL COMPATIBILITY AND JOINT FERTILITY ASSESSMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL PRECONCEPTION SCREENING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL PRECONCEPTION SCREENING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL PRECONCEPTION SCREENING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL SHARED GENETIC CARRIER SCREENING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL SHARED GENETIC CARRIER SCREENING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL SHARED GENETIC CARRIER SCREENING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL FERTILITY TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL URINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL URINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL URINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL BLOOD MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL BLOOD MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL BLOOD MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL SALIVA MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL SALIVA MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL SALIVA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL SEMEN MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL SEMEN MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL SEMEN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL CERVICAL MUCUS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL CERVICAL MUCUS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL CERVICAL MUCUS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL VAGINAL SWAB MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL VAGINAL SWAB MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL VAGINAL SWAB MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL TISSUE & BIOPSY SAMPLES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL TISSUE & BIOPSY SAMPLES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL TISSUE & BIOPSY SAMPLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL FERTILITY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL LATERAL FLOW IMMUNOASSAY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL LATERAL FLOW IMMUNOASSAY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL LATERAL FLOW IMMUNOASSAY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL CHEMILUMINESCENCE IMMUNOASSAY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL CHEMILUMINESCENCE IMMUNOASSAY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL CHEMILUMINESCENCE IMMUNOASSAY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL POLYMERASE CHAIN REACTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL POLYMERASE CHAIN REACTION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL POLYMERASE CHAIN REACTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL NEXT-GENERATION SEQUENCING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL NEXT-GENERATION SEQUENCING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL NEXT-GENERATION SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL MICROFLUIDICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL MICROFLUIDICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL MICROFLUIDICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL IMAGING-BASED DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL IMAGING-BASED DIAGNOSTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL IMAGING-BASED DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL DIGITAL AND SENSOR-BASED MONITORING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL DIGITAL AND SENSOR-BASED MONITORING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL DIGITAL AND SENSOR-BASED MONITORING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL FERTILITY TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL DIAGNOSTIC LABORATORIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL DIAGNOSTIC LABORATORIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL DIAGNOSTIC LABORATORIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL FERTILITY CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL FERTILITY CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL FERTILITY CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL HOME CARE USERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL HOME CARE USERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL HOME CARE USERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL RESEARCH INSTITUTES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL RESEARCH INSTITUTES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL RESEARCH INSTITUTES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 136. GLOBAL FERTILITY TESTING MARKET SIZE, BY MODE OF TESTING, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL AT-HOME TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 138. GLOBAL AT-HOME TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 139. GLOBAL AT-HOME TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 140. GLOBAL LABORATORY-BASED TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 141. GLOBAL LABORATORY-BASED TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 142. GLOBAL LABORATORY-BASED TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 143. GLOBAL POINT-OF-CARE TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 144. GLOBAL POINT-OF-CARE TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 145. GLOBAL POINT-OF-CARE TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 146. GLOBAL FERTILITY TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 147. ASIA-PACIFIC FERTILITY TESTING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 148. ASIA-PACIFIC FERTILITY TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 149. ASIA-PACIFIC FERTILITY TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 150. ASIA-PACIFIC FERTILITY TESTING MARKET SIZE, BY FEMALE FERTILITY TESTING, 2018-2032 (USD MILLION)
  • TABLE 151. ASIA-PACIFIC FERTILITY TESTING MARKET SIZE, BY MALE FERTILITY TESTING, 2018-2032 (USD MILLION)
  • TABLE 152. ASIA-PACIFIC FERTILITY TESTING MARKET SIZE, BY COUPLE FERTILITY TEST, 2018-2032 (USD MILLION)
  • TABLE 153. ASIA-PACIFIC FERTILITY TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 154. ASIA-PACIFIC FERTILITY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 155. ASIA-PACIFIC FERTILITY TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 156. ASIA-PACIFIC FERTILITY TESTING MARKET SIZE, BY MODE OF TESTING, 2018-2032 (USD MILLION)
  • TABLE 157. NORTH AMERICA FERTILITY TESTING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 158. NORTH AMERICA FERTILITY TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 159. NORTH AMERICA FERTILITY TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 160. NORTH AMERICA FERTILITY TESTING MARKET SIZE, BY FEMALE FERTILITY TESTING, 2018-2032 (USD MILLION)
  • TABLE 161. NORTH AMERICA FERTILITY TESTING MARKET SIZE, BY MALE FERTILITY TESTING, 2018-2032 (USD MILLION)
  • TABLE 162. NORTH AMERICA FERTILITY TESTING MARKET SIZE, BY COUPLE FERTILITY TEST, 2018-2032 (USD MILLION)
  • TABLE 163. NORTH AMERICA FERTILITY TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 164. NORTH AMERICA FERTILITY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 165. NORTH AMERICA FERTILITY TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 166. NORTH AMERICA FERTILITY TESTING MARKET SIZE, BY MODE OF TESTING, 2018-2032 (USD MILLION)
  • TABLE 167. LATIN AMERICA FERTILITY TESTING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 168. LATIN AMERICA FERTILITY TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 169. LATIN AMERICA FERTILITY TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 170. LATIN AMERICA FERTILITY TESTING MARKET SIZE, BY FEMALE FERTILITY TESTING, 2018-2032 (USD MILLION)
  • TABLE 171. LATIN AMERICA FERTILITY TESTING MARKET SIZE, BY MALE FERTILITY TESTING, 2018-2032 (USD MILLION)
  • TABLE 172. LATIN AMERICA FERTILITY TESTING MARKET SIZE, BY COUPLE FERTILITY TEST, 2018-2032 (USD MILLION)
  • TABLE 173. LATIN AMERICA FERTILITY TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 174. LATIN AMERICA FERTILITY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 175. LATIN AMERICA FERTILITY TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 176. LATIN AMERICA FERTILITY TESTING MARKET SIZE, BY MODE OF TESTING, 2018-2032 (USD MILLION)
  • TABLE 177. EUROPE FERTILITY TESTING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 178. EUROPE FERTILITY TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 179. EUROPE FERTILITY TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 180. EUROPE FERTILITY TESTING MARKET SIZE, BY FEMALE FERTILITY TESTING, 2018-2032 (USD MILLION)
  • TABLE 181. EUROPE FERTILITY TESTING MARKET SIZE, BY MALE FERTILITY TESTING, 2018-2032 (USD MILLION)
  • TABLE 182. EUROPE FERTILITY TESTING MARKET SIZE, BY COUPLE FERTILITY TEST, 2018-2032 (USD MILLION)
  • TABLE 183. EUROPE FERTILITY TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 184. EUROPE FERTILITY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 185. EUROPE FERTILITY TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 186. EUROPE FERTILITY TESTING MARKET SIZE, BY MODE OF TESTING, 2018-2032 (USD MILLION)
  • TABLE 187. MIDDLE EAST FERTILITY TESTING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 188. MIDDLE EAST FERTILITY TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 189. MIDDLE EAST FERTILITY TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 190. MIDDLE EAST FERTILITY TESTING MARKET SIZE, BY FEMALE FERTILITY TESTING, 2018-2032 (USD MILLION)
  • TABLE 191. MIDDLE EAST FERTILITY TESTING MARKET SIZE, BY MALE FERTILITY TESTING, 2018-2032 (USD MILLION)
  • TABLE 192. MIDDLE EAST FERTILITY TESTING MARKET SIZE, BY COUPLE FERTILITY TEST, 2018-2032 (USD MILLION)
  • TABLE 193. MIDDLE EAST FERTILITY TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 194. MIDDLE EAST FERTILITY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 195. MIDDLE EAST FERTILITY TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 196. MIDDLE EAST FERTILITY TESTING MARKET SIZE, BY MODE OF TESTING, 2018-2032 (USD MILLION)
  • TABLE 197. AFRICA FERTILITY TESTING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 198. AFRICA FERTILITY TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 199. AFRICA FERTILITY TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 200. AFRICA FERTILITY TESTING MARKET SIZE, BY FEMALE FERTILITY TESTING, 2018-2032 (USD MILLION)
  • TABLE 201. AFRICA FERTILITY TESTING MARKET SIZE, BY MALE FERTILITY TESTING, 2018-2032 (USD MILLION)
  • TABLE 202. AFRICA FERTILITY TESTING MARKET SIZE, BY COUPLE FERTILITY TEST, 2018-2032 (USD MILLION)
  • TABLE 203. AFRICA FERTILITY TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 204. AFRICA FERTILITY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 205. AFRICA FERTILITY TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 206. AFRICA FERTILITY TESTING MARKET SIZE, BY MODE OF TESTING, 2018-2032 (USD MILLION)
  • TABLE 207. GLOBAL FERTILITY TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 208. ASEAN FERTILITY TESTING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 209. ASEAN FERTILITY TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 210. ASEAN FERTILITY TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 211. ASEAN FERTILITY TESTING MARKET SIZE, BY FEMALE FERTILITY TESTING, 2018-2032 (USD MILLION)
  • TABLE 212. ASEAN FERTILITY TESTING MARKET SIZE, BY MALE FERTILITY TESTING, 2018-2032 (USD MILLION)
  • TABLE 213. ASEAN FERTILITY TESTING MARKET SIZE, BY COUPLE FERTILITY TEST, 2018-2032 (USD MILLION)
  • TABLE 214. ASEAN FERTILITY TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 215. ASEAN FERTILITY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 216. ASEAN FERTILITY TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 217. ASEAN FERTILITY TESTING MARKET SIZE, BY MODE OF TESTING, 2018-2032 (USD MILLION)
  • TABLE 218. GCC FERTILITY TESTING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 219. GCC FERTILITY TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 220. GCC FERTILITY TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 221. GCC FERTILITY TESTING MARKET SIZE, BY FEMALE FERTILITY TESTING, 2018-2032 (USD MILLION)
  • TABLE 222. GCC FERTILITY TESTING MARKET SIZE, BY MALE FERTILITY TESTING, 2018-2032 (USD MILLION)
  • TABLE 223. GCC FERTILITY TESTING MARKET SIZE, BY COUPLE FERTILITY TEST, 2018-2032 (USD MILLION)
  • TABLE 224. GCC FERTILITY TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 225. GCC FERTILITY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 226. GCC FERTILITY TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 227. GCC FERTILITY TESTING MARKET SIZE, BY MODE OF TESTING, 2018-2032 (USD MILLION)
  • TABLE 228. EUROPEAN UNION FERTILITY TESTING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 229. EUROPEAN UNION FERTILITY TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 230. EUROPEAN UNION FERTILITY TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 231. EUROPEAN UNION FERTILITY TESTING MARKET SIZE, BY FEMALE FERTILITY TESTING, 2018-2032 (USD MILLION)
  • TABLE 232. EUROPEAN UNION FERTILITY TESTING MARKET SIZE, BY MALE FERTILITY TESTING, 2018-2032 (USD MILLION)
  • TABLE 233. EUROPEAN UNION FERTILITY TESTING MARKET SIZE, BY COUPLE FERTILITY TEST, 2018-2032 (USD MILLION)
  • TABLE 234. EUROPEAN UNION FERTILITY TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 235. EUROPEAN UNION FERTILITY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 236. EUROPEAN UNION FERTILITY TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 237. EUROPEAN UNION FERTILITY TESTING MARKET SIZE, BY MODE OF TESTING, 2018-2032 (USD MILLION)
  • TABLE 238. BRICS FERTILITY TESTING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 239. BRICS FERTILITY TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 240. BRICS FERTILITY TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 241. BRICS FERTILITY TESTING MARKET SIZE, BY FEMALE FERTILITY TESTING, 2018-2032 (USD MILLION)
  • TABLE 242. BRICS FERTILITY TESTING MARKET SIZE, BY MALE FERTILITY TESTING, 2018-2032 (USD MILLION)
  • TABLE 243. BRICS FERTILITY TESTING MARKET SIZE, BY COUPLE FERTILITY TEST, 2018-2032 (USD MILLION)
  • TABLE 244. BRICS FERTILITY TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 245. BRICS FERTILITY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 246. BRICS FERTILITY TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 247. BRICS FERTILITY TESTING MARKET SIZE, BY MODE OF TESTING, 2018-2032 (USD MILLION)
  • TABLE 248. G7 FERTILITY TESTING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 249. G7 FERTILITY TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 250. G7 FERTILITY TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 251. G7 FERTILITY TESTING MARKET SIZE, BY FEMALE FERTILITY TESTING, 2018-2032 (USD MILLION)
  • TABLE 252. G7 FERTILITY TESTING MARKET SIZE, BY MALE FERTILITY TESTING, 2018-2032 (USD MILLION)
  • TABLE 253. G7 FERTILITY TESTING MARKET SIZE, BY COUPLE FERTILITY TEST, 2018-2032 (USD MILLION)
  • TABLE 254. G7 FERTILITY TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 255. G7 FERTILITY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 256. G7 FERTILITY TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 257. G7 FERTILITY TESTING MARKET SIZE, BY MODE OF TESTING, 2018-2032 (USD MILLION)
  • TABLE 258. NATO FERTILITY TESTING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 259. NATO FERTILITY TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 260. NATO FERTILITY TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 261. NATO FERTILITY TESTING MARKET SIZE, BY FEMALE FERTILITY TESTING, 2018-2032 (USD MILLION)
  • TABLE 262. NATO FERTILITY TESTING MARKET SIZE, BY MALE FERTILITY TESTING, 2018-2032 (USD MILLION)
  • TABLE 263. NATO FERTILITY TESTING MARKET SIZE, BY COUPLE FERTILITY TEST, 2018-2032 (USD MILLION)
  • TABLE 264. NATO FERTILITY TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 265. NATO FERTILITY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 266. NATO FERTILITY TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 267. NATO FERTILITY TESTING MARKET SIZE, BY MODE OF TESTING, 2018-2032 (USD MILLION)
  • TABLE 268. GLOBAL FERTILITY TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 269. UNITED STATES FERTILITY TESTING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 270. UNITED STATES FERTILITY TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 271. UNITED STATES FERTILITY TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 272. UNITED STATES FERTILITY TESTING MARKET SIZE, BY FEMALE FERTILITY TESTING, 2018-2032 (USD MILLION)
  • TABLE 273. UNITED STATES FERTILITY TESTING MARKET SIZE, BY MALE FERTILITY TESTING, 2018-2032 (USD MILLION)
  • TABLE 274. UNITED STATES FERTILITY TESTING MARKET SIZE, BY COUPLE FERTILITY TEST, 2018-2032 (USD MILLION)
  • TABLE 275. UNITED STATES FERTILITY TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 276. UNITED STATES FERTILITY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 277. UNITED STATES FERTILITY TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 278. UNITED STATES FERTILITY TESTING MARKET SIZE, BY MODE OF TESTING, 2018-2032 (USD MILLION)
  • TABLE 279. CANADA FERTILITY TESTING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 280. CANADA FERTILITY TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 281. CANADA FERTILITY TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 282. CANADA FERTILITY TESTING MARKET SIZE, BY FEMALE FERTILITY TESTING, 2018-2032 (USD MILLION)
  • TABLE 283. CANADA FERTILITY TESTING MARKET SIZE, BY MALE FERTILITY TESTING, 2018-2032 (USD MILLION)
  • TABLE 284. CANADA FERTILITY TESTING MARKET SIZE, BY COUPLE FERTILITY TEST, 2018-2032 (USD MILLION)
  • TABLE 285. CANADA FERTILITY TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 286. CANADA FERTILITY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 287. CANADA FERTILITY TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 288. CANADA FERTILITY TESTING MARKET SIZE, BY MODE OF TESTING, 2018-2032 (USD MILLION)
  • TABLE 289. MEXICO FERTILITY TESTING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 290. MEXICO FERTILITY TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 291. MEXICO FERTILITY TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 292. MEXICO FERTILITY TESTING MARKET SIZE, BY FEMALE FERTILITY TESTING, 2018-2032 (USD MILLION)
  • TABLE 293. MEXICO FERTILITY TESTING MARKET SIZE, BY MALE FERTILITY TESTING, 2018-2032 (USD MILLION)
  • TABLE 294. MEXICO FERTILITY TESTING MARKET SIZE, BY COUPLE FERTILITY TEST, 2018-2032 (USD MILLION)
  • TABLE 295. MEXICO FERTILITY TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 296. MEXICO FERTILITY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 297. MEXICO FERTILITY TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 298. MEXICO FERTILITY TESTING MARKET SIZE, BY MODE OF TESTING, 2018-2032 (USD MILLION)
  • TABLE 299. BRAZIL FERTILITY TESTING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 300. BRAZIL FERTILITY TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 301. BRAZIL FERTILITY TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 302. BRAZIL FERTILITY TESTING MARKET SIZE, BY FEMALE FERTILITY TESTING, 2018-2032 (USD MILLION)
  • TABLE 303. BRAZIL FERTILITY TESTING MARKET SIZE, BY MALE FERTILITY TESTING, 2018-2032 (USD MILLION)
  • TABLE 304. BRAZIL FERTILITY TESTING MARKET SIZE, BY COUPLE FERTILITY TEST, 2018-2032 (USD MILLION)
  • TABLE 305. BRAZIL FERTILITY TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 306. BRAZIL FERTILITY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 307. BRAZIL FERTILITY TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 308. BRAZIL FERTILITY TESTING MARKET SIZE, BY MODE OF TESTING, 2018-2032 (USD MILLION)
  • TABLE 309. UNITED KINGDOM FERTILITY TESTING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 310. UNITED KINGDOM FERTILITY TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 311. UNITED KINGDOM FERTILITY TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 312. UNITED KINGDOM FERTILITY TESTING MARKET SIZE, BY FEMALE FERTILITY TESTING, 2018-2032 (USD MILLION)
  • TABLE 313. UNITED KINGDOM FERTILITY TESTING MARKET SIZE, BY MALE FERTILITY TESTING, 2018-2032 (USD MILLION)
  • TABLE 314. UNITED KINGDOM FERTILITY TESTING MARKET SIZE, BY COUPLE FERTILITY TEST, 2018-2032 (USD MILLION)
  • TABLE 315. UNITED KINGDOM FERTILITY TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 316. UNITED KINGDOM FERTILITY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 317. UNITED KINGDOM FERTILITY TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 318. UNITED KINGDOM FERTILITY TESTING MARKET SIZE, BY MODE OF TESTING, 2018-2032 (USD MILLION)
  • TABLE 319. GERMANY FERTILITY TESTING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 320. GERMANY FERTILITY TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 321. GERMANY FERTILITY TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 322. GERMANY FERTILITY TESTING MARKET SIZE, BY FEMALE FERTILITY TESTING, 2018-2032 (USD MILLION)
  • TABLE 323. GERMANY FERTILITY TESTING MARKET SIZE, BY MALE FERTILITY TESTING, 2018-2032 (USD MILLION)
  • TABLE 324. GERMANY FERTILITY TESTING MARKET SIZE, BY COUPLE FERTILITY TEST, 2018-2032 (USD MILLION)
  • TABLE 325. GERMANY FERTILITY TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 326. GERMANY FERTILITY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 327. GERMANY FERTILITY TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 328. GERMANY FERTILITY TESTING MARKET SIZE, BY MODE OF TESTING, 2018-2032 (USD MILLION)
  • TABLE 329. FRANCE FERTILITY TESTING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 330. FRANCE FERTILITY TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 331. FRANCE FERTILITY TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 332. FRANCE FERTILITY TESTING MARKET SIZE, BY FEMALE FERTILITY TESTING, 2018-2032 (USD MILLION)
  • TABLE 333. FRANCE FERTILITY TESTING MARKET SIZE, BY MALE FERTILITY TESTING, 2018-2032 (USD MILLION)
  • TABLE 334. FRANCE FERTILITY TESTING MARKET SIZE, BY COUPLE FERTILITY TEST, 2018-2032 (USD MILLION)
  • TABLE 335. FRANCE FERTILITY TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 336. FRANCE FERTILITY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 337. FRANCE FERTILITY TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 338. FRANCE FERTILITY TESTING MARKET SIZE, BY MODE OF TESTING, 2018-2032 (USD MILLION)
  • TABLE 339. RUSSIA FERTILITY TESTING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 340. RUSSIA FERTILITY TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 341. RUSSIA FERTILITY TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 342. RUSSIA FERTILITY TESTING MARKET SIZE, BY FEMALE FERTILITY TESTING, 2018-2032 (USD MILLION)
  • TABLE 343. RUSSIA FERTILITY TESTING MARKET SIZE, BY MALE FERTILITY TESTING, 2018-2032 (USD MILLION)
  • TABLE 344. RUSSIA FERTILITY TESTING MARKET SIZE, BY COUPLE FERTILITY TEST, 2018-2032 (USD MILLION)
  • TABLE 345. RUSSIA FERTILITY TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 346. RUSSIA FERTILITY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 347. RUSSIA FERTILITY TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 348. RUSSIA FERTILITY TESTING MARKET SIZE, BY MODE OF TESTING, 2018-2032 (USD MILLION)
  • TABLE 349. ITALY FERTILITY TESTING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 350. ITALY FERTILITY TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 351. ITALY FERTILITY TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 352. ITALY FERTILITY TESTING MARKET SIZE, BY FEMALE FERTILITY TESTING, 2018-2032 (USD MILLION)
  • TABLE 353. ITALY FERTILITY TESTING MARKET SIZE, BY MALE FERTILITY TESTING, 2018-2032 (USD MILLION)
  • TABLE 354. ITALY FERTILITY TESTING MARKET SIZE, BY COUPLE FERTILITY TEST, 2018-2032 (USD MILLION)
  • TABLE 355. ITALY FERTILITY TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 356. ITALY FERTILITY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 357. ITALY FERTILITY TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 358. ITALY FERTILITY TESTING MARKET SIZE, BY MODE OF TESTING, 2018-2032 (USD MILLION)
  • TABLE 359. SPAIN FERTILITY TESTING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 360. SPAIN FERTILITY TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 361. SPAIN FERTILITY TESTING MAR